The Lupus Foundation of America, North Carolina Chapter (LFANC) has appointed Kelly Carraway to its board of directors.
Carraway is a real estate broker at Century 21 Triangle Group. A native of Raleigh, she is active in her community as a volunteer and as a member of various Chambers of Commerce, the National Association of REALTORS and Raleigh Regional Association of REALTORS. Carraway attended East Carolina University where she studied business. She received her Dental Assistant II Certification from Bowman Gray at Wake Forest University.
“We are excited to welcome Kelly [Carraway] to our board of directors,” said Christine John-Fuller, President & CEO of LFANC. “She brings a strong foundation of experience and relationships in the Triangle area. That combined with her passion for raising awareness about this disease will help us further our mission in serving the 45,000 individuals living with lupus throughout North Carolina .”
About Lupus:
Lupus is an unpredictable and misunderstood autoimmune disease that ravages different parts of the body. It is difficult to diagnose, hard to live with, and a challenge to treat. Lupus is a cruel mystery because it is hidden from view and undefined, has a range of symptoms, hits out of nowhere, and has no known cause and no known cure. Its health effects can range from a skin rash to a heart attack. Lupus is debilitating and destructive, and can be fatal, yet research on lupus remains underfunded relative to its scope and devastation.
About the Lupus Foundation of America, North Carolina Chapter
The Lupus Foundation of America, North Carolina Chapter is part of the national force devoted to solving the cruel mystery of lupus while providing caring support to those who suffer from its brutal impact. Serving an estimated 45,000 living with lupus in North Carolina, the chapter is the center of excellence for those affected by lupus, bridging patients, their families, caregivers, and the medical community. For more information about lupus or the LFANC, visit www.lupusnc.org or call (877) 849-8271. For the latest news and updates, follow us on Facebook, Twitter and Instagram.